Private Support

November 2021 Funding Opportunities

 

Leukemia and Lymphoma Society

1. Program: Scholars Career Development Award
Purpose: To support talented blood cancer researchers to advance the understanding and diagnosis of blood cancer, as well as the development of treatment and prevention options that will ultimately lead to a higher quality of life for blood cancer patients as well as potential cures. Scholar applicants are primarily basic and translational researchers.
Eligibility: Applicants must:

  • Have a Sponsor who will attest to institutional support for the applicant.
  • Be an independent investigator of at least an assistant professor position or equivalent.
  • Have adequate funding to support the proposed research (see Research Support Requirement).
  • Have started their first independent position no less than 2 years but not more than 8 years before the time of review (see Experience/eligibility clock).  Instructor-level positions are not counted as independent for eligibility purposes.
  • Have at least one full length (which may include short reports), peer-reviewed, primary research, corresponding author publication.

Funding: $120,000 per year for five years (inclusive of 5% indirects).
Deadline: Eligibility requirements are due November 1st; abstracts are due November 15th and full proposals are due December 17th.
Considering applying? Please contact Kathryn DeRobertis, BUMC Senior Foundation Relations Associate, ksdero@bu.edu, to convey intent to apply and (optional) request assistance. BMC investigators can contact Jennifer Fleming, BMC Director of Foundation Relations and Government Grants, jennifer.fleming@bmc.org.
Details

2. Program: Scholar in Clinical Research Career Development Award
Purpose: To support researchers who are on a trajectory for leadership in blood cancer clinical research.
Eligibility: Scholar in Clinical Research applicants must:

  • Have a Sponsor who will attest to institutional support for the applicant.
  • Be an independent investigator of at least an assistant professor position or equivalent; this includes any permanent, independent clinical faculty who are not on a laboratory-based, tenure-track career path.
  • Have clinical training in blood cancer.
  • Have adequate funding to support the proposed research (see Research Support Requirement).
  • Have started their first independent position no less than 4 years but not more than 10 years before the time of review (see Experience/eligibility clock). Instructor-level positions are not counted as independent for eligibility purposes.
  • Have protected time for research after the funding start date in the range of 20-40%. Deviations from this may be allowed and will be determined on a case-by-case basis by LLS scientific staff.
  • Have a least one first author, full length (which may include short reports), peer-reviewed, primary research publication available on PubMed by the full application due date* (Not including reviews, perspectives, conference/meeting presentations or abstracts, etc.). Note that those applicants with no corresponding author publications are eligible but are less likely to be competitive.
  • Be performing clinical research involving patients (generally clinical trials), which is related to their clinical duties. Laboratory correlative studies are welcome, but laboratory studies must directly relate to the clinical studies.
  • Funding: $125,000 per year for five years (inclusive of 5% indirects).
    Deadline: Eligibility requirements are due November 1st; abstracts are due November 15th and full proposals are due December 17th.
    Considering applying? Please contact Kathryn DeRobertis, BUMC Senior Foundation Relations Associate, ksdero@bu.edu, to convey intent to apply and (optional) request assistance. BMC investigators can contact Jennifer Fleming, BMC Director of Foundation Relations and Government Grants, jennifer.fleming@bmc.org.
    Details

    3. Program: Special Fellow Career Development Award
    Purpose: To support talented blood cancer researchers in the early phase of their careers to advance the understanding and diagnosis of blood cancer, as well as the development of treatment and prevention options that will ultimately lead to a higher quality of life for blood cancer patients as well as potential cures.
    Eligibility: Special Fellow applicants must •Have a sponsor

  • Be a postdoc in their Sponsor’s lab by the award start date
  • Not be in a graduate program at the award start date
  • Have a least one first author, full length (which may include short reports), peer-reviewed, primary research publication available on PubMed by the full application due date
  • Have a total of postdoctoral experience that is at least 3 years, but no more than 5 years at the time of the award start date (see below for more details)
  • Not have any unexplained gaps in training
  • Funding: $67,000 per year for two or three years (inclusive of 5% indirects).
    Deadline: Eligibility requirements are due November 1st; abstracts are due November 15th and full proposals are due December 17th.
    Considering applying? Please contact Kathryn DeRobertis, BUMC Senior Foundation Relations Associate, ksdero@bu.edu, to convey intent to apply and (optional) request assistance. BMC investigators can contact Jennifer Fleming, BMC Director of Foundation Relations and Government Grants, jennifer.fleming@bmc.org.
    Details

    4. Program: Fellow Career Development Award
    Purpose: To support talented blood cancer researchers in the early phase of their careers to advance the understanding and diagnosis of blood cancer, as well as the development of treatment and prevention options that will ultimately lead to a higher quality of life for blood cancer patients as well as potential cures.
    Eligibility: Fellow applicants must •Have a sponsor

  • Be a postdoc in their Sponsor’s lab at the time of full application submission
  • Not be in a graduate program at the award start date
  • Have a least one first author, full length (which may include short reports), peer-reviewed, primary research publication available on PubMed by the full application due date
  • Not have any unexplained gaps in training
  • Not have more than 3 years oftotal postdoctoral experience by the award start date (see below for more details)
  • Funding: $60,000 per year for two or three years (inclusive of 5% indirects).
    Deadline: Eligibility requirements are due November 1st; abstracts are due November 15th and full proposals are due December 17th.
    Considering applying? Please contact Kathryn DeRobertis, BUMC Senior Foundation Relations Associate, ksdero@bu.edu, to convey intent to apply and (optional) request assistance. BMC investigators can contact Jennifer Fleming, BMC Director of Foundation Relations and Government Grants, jennifer.fleming@bmc.org.
    Details

    DeGregorio Family Foundation

    Program: Award for Cancers of the Esophagus and Stomach
    Purpose: To support high quality, innovative, and transformative translational and bench research to improve the understanding of the biology of upper gastrointestinal malignancies, identification of potential novel therapeutic targets, or in the development and evaluation of novel biomarkers for early diagnosis and treatment. Pre-clinical research, basic mechanistic studies, genomic/epigenomic studies, as well as epidemiologic studies may also be supported.
    Eligibility: Research projects must not be funded currently under a separate mechanism.
    Funding: $250,000 over 2 years (inclusive of 10% indirects).
    Deadline: Applications are due November 2nd.
    Considering applying? Please contact Kathryn DeRobertis, BUMC Senior Foundation Relations Associate, ksdero@bu.edu, to convey intent to apply and (optional) request assistance. BMC investigators can contact Jennifer Fleming, BMC Director of Foundation Relations and Government Grants, jennifer.fleming@bmc.org.
    Details

    American Association for Cancer Research

    1. Program: Bristol Myers Squibb Midcareer Female Investigator Grant
    Purpose: To encourage and support mid-career female physician-scientists and researchers to conduct immuno-oncology research and to foster their career advancement toward becoming a senior investigator. Research projects may be translational and/or clinical in nature with a focus on immuno-oncology.
    Eligibility: Applicants must have a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree. Applicants must also have received their first NIH R01 (or equivalent) award within the past 10 years (i.e., grant cannot have been awarded before July 1, 2012) and must hold an appointment at the rank of associate professor as of July 1, 2022.
    Funding: $225,000 over three years (no indirects).
    Deadline: Applications are due November 11th.
    Considering applying? Please contact Kathryn DeRobertis, BUMC Senior Foundation Relations Associate, ksdero@bu.edu, to convey intent to apply and (optional) request assistance. BMC investigators can contact Jennifer Fleming, BMC Director of Foundation Relations and Government Grants, jennifer.fleming@bmc.org.
    Details

    2. Program: the ASCO Foundation Young Investigator Award for Translational Cancer Research
    Purpose: To provide funding to promising investigators to encourage and promote quality research in clinical oncology and to fund a physician-scientist during the transition from a fellowship program to a faculty appointment. Research projects are restricted to translational cancer research.
    Eligibility: At the start of the grant term on July 1, 2022, applicants must be in the last two years of their final subspecialty training and within 10 years of obtaining their medical degree.
    Funding: $50,000 for 1 year (inclusive of 5% indirects).
    Deadline: Applications due November 9th.
    Considering applying? Please contact Kathryn DeRobertis, BUMC Senior Foundation Relations Associate, ksdero@bu.edu, to convey intent to apply and (optional) request assistance. BMC investigators can contact Jennifer Fleming, BMC Director of Foundation Relations and Government Grants, jennifer.fleming@bmc.org.
    Details

    American Gastroenterological Association

    Program: Bern Schwartz Family Fund Research Scholar Award in Pancreatic Cancer
    Purpose: To support early-career investigators working toward independent and productive careers in pancreatic cancer research. The proposed research must focus on the pathophysiology, epidemiology, prevention, diagnosis, treatment or patient outcomes of pancreatic cancer.
    Eligibility: MD (or equivalent) applicants must have completed clinical training (GI fellowship or its equivalent) within 8 years of the start date of this award (July 2022). PhD (or equivalent) applicants must have conferred the PhD degree within 8 years of the start date of this award (July 2022). At the time of application submission, applicants may not hold, or have held, a NIH K01, K08, K23, K99, R00, R01, R21, R29, Veterans Affairs Career Development Award or any award with similar objectives from non-federal sources.
    Funding: $300,000 over three years (no indirects).
    Deadline: Applications are due November 10th.
    Considering applying? Please contact Kathryn DeRobertis, BUMC Senior Foundation Relations Associate, ksdero@bu.edu, to convey intent to apply and (optional) request assistance. BMC investigators can contact Jennifer Fleming, BMC Director of Foundation Relations and Government Grants, jennifer.fleming@bmc.org.
    Details

    Alex’s Lemonade Stand

    Program: Innovation Grants
    Purpose: To provide critical and significant seed funding for experienced investigators with a novel and promising approach to finding causes and cures for childhood cancers. Proposals should have clinical translation in view. This may represent a change in research direction and/or an innovative new idea that moves away from an investigator’s prior research but for which a strong case is made for the potential impact on childhood cancers.
    Eligibility: Track record of publication and funding productivity in the last 5 years must demonstrate that the project can be accomplished by the investigator(s). Grants must be focused on pediatric translational oncology, from understanding basic biologic underpinnings to new therapies.
    Funding: $250,000 over two years (no indirects).
    Deadline: LOIs due November 15th; invited full applications due April 4th.
    Considering applying? Please contact Kathryn DeRobertis, BUMC Senior Foundation Relations Associate, ksdero@bu.edu, to convey intent to apply and (optional) request assistance. BMC investigators can contact Jennifer Fleming, BMC Director of Foundation Relations and Government Grants, jennifer.fleming@bmc.org.
    Details

    Cancer Research Institute

    Program: Technology Impact Award
    Purpose: To provide seed funding to address the gap between technology development and clinical application of cancer immunotherapies. These grants aim to encourage collaboration between technology developers and clinical cancer immunologists and to generate the proof-of-principle of a novel platform technology in bioinformatics, ex vivo or in silico modeling systems, immunological or tumor profiling instrumentation, methods, reagents and assays, or other relevant technologies.
    Eligibility: Applicants must hold a faculty appointment as a tenure-track assistant professor (or higher rank) at the time of award activation.
    Funding: $200,000 over 2 years (no indirects).
    Deadline: LOIs are due November 15th; invited full proposals will be due March 15th.
    Considering applying? Please contact Kathryn DeRobertis, BUMC Senior Foundation Relations Associate, ksdero@bu.edu, to convey intent to apply and (optional) request assistance. BMC investigators can contact Jennifer Fleming, BMC Director of Foundation Relations and Government Grants, jennifer.fleming@bmc.org.
    Details

    Stand Up To Cancer

    Program: Lung Cancer Health Equity SU2C Catalyst Program
    Purpose: To address the issue of low participation by racial and ethnic minority populations in cancer research and unequal access to cancer care despite the disproportionate burden of disease in those groups. The proposed project should target patients with non-small cell lung cancer (NSCLC) eligible for immunotherapy combinations, with particular emphasis on people of color and minority patients in medically underserved communities.
    This Lung Cancer Health Equity SU2C Catalyst Program will focus on developing scalable solutions that address provider-level barriers by leveraging remote and virtual care technologies augmented with Artificial Intelligence (AI) in an innovative care delivery model, leveraging services and tools from Apricity Health. Technology-enabled AI-assisted services include: 1.AI decision support to augment the expertise of practicing oncology teams at points-of-care to ensure guideline-based best practice in real world care
    2.Digital technology to monitor patients while at home in between clinic visits so the appropriate care can be extended to patients at the proper time without delay
    3.On demand staff augmentation strategy to address the shortage of oncology expert care providers that contributes to coverage gaps in these communities
    4.Incorporation of in-home supportive care, or under certain circumstances, home hospitalization for those with significant care distance barriers.
    Eligibility: The research team must include clinical and evaluation expertise, including senior and early-career investigators. The Team will consist of a Team Leader, a Team Co-Leader, no more than four additional Team Principals, a Project Manager, and at least one Patient Advocate, with a minimum of three participating institutions. Racial and ethnic diversity among SU2C Catalyst Team personnel is strongly encouraged.
    Funding: Teams may apply for total support up to $1 million over a 3- year term, including indirect costs up to 25 percent, in addition to technology-enabled care services by Apricity Health that will be provided (not included in Catalyst Team budget) to support patient care.
    Deadline: Applications are due November 16th. The Team Leader and Co-Leader of the finalist teams will be required to present the proposal at a virtual selection meeting to be held on Friday, January 21st.
    Considering applying? Please contact Kathryn DeRobertis, BUMC Senior Foundation Relations Associate, ksdero@bu.edu, to convey intent to apply and (optional) request assistance. BMC investigators can contact Jennifer Fleming, BMC Director of Foundation Relations and Government Grants, jennifer.fleming@bmc.org.
    Details

    Melanoma Research Alliance

    1. Program: Pilot Award
    Purpose: To support senior investigators who propose potentially transformative ideas that do not have extensive preliminary data but articulate a clear hypothesis and translational goals.
    Eligibility: Applicants must a senior investigator (past the initial four years of their first academic faculty appointment) and hold a full-time faculty appointment at the level of Assistant Professor (or equivalent) or above.
    Funding: $100,000 over 2 years (no indirects).
    Deadline: Applications are due November 17th.
    Considering applying? Please contact Kathryn DeRobertis, BUMC Senior Foundation Relations Associate, ksdero@bu.edu, to convey intent to apply and (optional) request assistance. BMC investigators can contact Jennifer Fleming, BMC Director of Foundation Relations and Government Grants, jennifer.fleming@bmc.org.
    Details

    2. Program: Pilot Award for Women in Melanoma Research
    Purpose: To support female senior investigators who propose potentially transformative ideas that do not have extensive preliminary data but articulate a clear hypothesis and translational goals.
    Eligibility: Applicants must a senior investigator (past the initial four years of their first academic faculty appointment) and hold a full-time faculty appointment at the level of Assistant Professor (or equivalent) or above. For this Award, the PI must be a woman.
    Funding: $100,000 over 2 years (no indirects).
    Deadline: Applications are due November 17th.
    Considering applying? Please contact Kathryn DeRobertis, BUMC Senior Foundation Relations Associate, ksdero@bu.edu, to convey intent to apply and (optional) request assistance. BMC investigators can contact Jennifer Fleming, BMC Director of Foundation Relations and Government Grants, jennifer.fleming@bmc.org.
    Details

    3. Program: Young Investigator Award
    Purpose: To recruit and support the next generation of melanoma research leaders. Awardees will be provided funding to accomplish innovative and original, preclinical, translational, and/or early clinical research projects.
    Eligibility: Applicants must be within the first five years of their first independent, full time academic faculty appointment at the application deadline at the level of Assistant Professor (or equivalent position). A mentorship commitment from a senior investigator is required.
    Funding: $255,000 over three years (no indirects).
    Deadline: Applicant checklists are November 3rd; full proposals due November 17th.
    Considering applying? Please contact Kathryn DeRobertis, BUMC Senior Foundation Relations Associate, ksdero@bu.edu, to convey intent to apply and (optional) request assistance. BMC investigators can contact Jennifer Fleming, BMC Director of Foundation Relations and Government Grants, jennifer.fleming@bmc.org.
    Details

    4. Program: Bristol-Myers Squibb-MRA Young Investigator Awards In Immunotherapy
    Purpose: To support early career faculty accomplish innovative and original, preclinical, translational, and/or early clinical research projects in the field of melanoma. Projects must be supported by preliminary data and focused on advancing immunotherapies in melanoma.
    Eligibility: Applicants must be within the first five years of their first independent, full time academic faculty appointment at the application deadline at the level of Assistant Professor (or equivalent position). A mentorship commitment from a senior investigator is required.
    Funding: $255,000 over three years (no indirects).
    Deadline: Applicant checklists are November 3rd; full proposals due November 17th.
    Considering applying? Please contact Kathryn DeRobertis, BUMC Senior Foundation Relations Associate, ksdero@bu.edu, to convey intent to apply and (optional) request assistance. BMC investigators can contact Jennifer Fleming, BMC Director of Foundation Relations and Government Grants, jennifer.fleming@bmc.org.
    Details

    5. Program: Young Investigator Award for Women in Melanoma Research
    Purpose: To support female melanoma research leaders. Awardees will be provided funding to accomplish innovative and original, preclinical, translational, and/or early clinical research projects.
    Eligibility: Applicants must be within the first five years of their first independent, full time academic faculty appointment at the application deadline at the level of Assistant Professor (or equivalent position). A mentorship commitment from a senior investigator is required. For this Award, the PI must be a woman.
    Funding: $255,000 over three years (no indirects).
    Deadline: Applicant checklists are November 3rd; full proposals due November 17th.
    Considering applying? Please contact Kathryn DeRobertis, BUMC Senior Foundation Relations Associate,ksdero@bu.edu, to convey intent to apply and (optional) request assistance. BMC investigators can contact Jennifer Fleming, BMC Director of Foundation Relations and Government Grants, jennifer.fleming@bmc.org.
    Details

    Terri Brodeur Breast Cancer Foundation

    Program: Fellowship Grants
    Purpose: To support early stage physician scientist to enable them to develop independent programs and compelling careers in breast cancer research. The foundation seeks to fund broadly across all relevant disciplines and as such focus areas can include basic, preclinical, clinical research and clinical care.
    Eligibility: PhD, MD/PhD and MD physician scientists at earlier stages of their careers.
    Funding: $100,000 over 2 years (no indirects).
    Deadline: Applications are due November 19th.
    Considering applying? Please contact Kathryn DeRobertis, BUMC Senior Foundation Relations Associate, ksdero@bu.edu, to convey intent to apply and (optional) request assistance. BMC investigators can contact Jennifer Fleming, BMC Director of Foundation Relations and Government Grants, jennifer.fleming@bmc.org.
    Details

    BU’s Office of Foundation Relations can assist faculty members in preparing and submitting applications. If you are pursuing any of the following funding opportunities, please contact Kathryn DeRobertis, BUMC Senior Foundation Relations Associate, ksdero@bu.edu, so applications can be coordinated and tracked.